Abbott i-STAT EG7+ Blood Gas Cartridges Reporting Inaccurate Results
Abbott Point Of Care is recalling approximately 7.6% of specific i-STAT EG7+ cartridge lots due to a manufacturing issue causing falsely high pCO2 and low pH readings. Inaccurate results could lead clinicians to make unnecessary or harmful medical interventions.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of medical devices that pose risk of harm to patients (potential for unnecessary harmful clinical interventions and delayed diagnosis). The source states no illnesses or injuries have been reported, making the severity a High (3) rather than Severe (4), per the rubric criterion for risk-of-harm products without reported injury.
Plain-English summary
Abbott Point Of Care Inc. is recalling specific lots of i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25), and i-STAT G3+ (list number 03P78-26) blood gas cartridges due to a manufacturing issue. Approximately 7.6% of cartridges from affected lots in the U.S. marketplace may report higher than expected pCO2 and lower than expected pH results.
The inaccurate results can make blood gas readings appear as though a patient is in severe respiratory acidosis when they are not. If clinicians rely on these false values, they may implement unnecessary or potentially harmful interventions, including unnecessary ventilator adjustments, unnecessary medications, potential harm from overcorrection, or delays in identifying the patient's true clinical condition.
The recalled cartridges were distributed worldwide, including throughout the United States and to Canada, Austria, Bangladesh, Belgium, Finland, France, Germany, Ireland, Italy, Luxembourg, Mauritius, Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. A total of 369,650 units were distributed (150,875 in the U.S., 218,775 outside the U.S.). Affected lot numbers are N25206, N25207, N25209, N25213, N25218, N25219, and N25233.
The recalled product
- Product
- i-STAT EG7+ cartridge; List Number: 03P76-25;
- Manufacturer
- Abbott Point Of Care Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- List Number: 03P76-25
- UDI-DI: 00054749000043
- Lot numbers: N25206
- N25207
- N25209
- N25213
- N25218
- N25219
- N25233
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Abbott Point Of Care Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Abbott Point Of Care Inc.
See all →- Highi-STAT Blood Gas Analyzer Cartridges Recalled for Inaccurate Results
FDA (Devices) · 2026-05-06
- HighAbbott i-STAT Blood Gas Cartridges Reporting Inaccurate pH and PCO2 Results
FDA (Devices) · 2026-05-06
- ModerateBlood gas EG7+ cartridges recalled for lacking updated premarket clearance
FDA (Devices) · 2025-09-24
- ModerateBlood gas EG6+ cartridges recalled for lacking updated premarket clearance
FDA (Devices) · 2025-09-24
- ModerateBlood gas CG8+ cartridges recalled for lacking updated premarket clearance
FDA (Devices) · 2025-09-24
Same hazard · inaccurate results
See all →- HighHealthmark Protein Test Recalled Due to Expired Ingredient
FDA (Devices) · 2026-09-02
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- Highepoc BGEM BUN Test Card for epoc Blood Analysis System
FDA (Devices) · 2026-05-06
- HighAtellica hemoglobin A1c assay may return depressed patient results
FDA (Devices) · 2026-04-08